Glioma
Conditions
Interventions
Experimental Group:Combined Chemotherapy and radiotherapy with Nituzumab
Control Group:No
Sponsors
Beijing Huaxin Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Surgery has been performed on the primary brain lesion and the pathological diagnosis is clear. 2. Expected Survival greater than 3 months; 3. Physical Fitness Score >=60; 4. Patients had good compliance and were able to understand and support the study and sign informed consent forms.
Exclusion criteria
Exclusion criteria: 1. There were more than 2 kinds of primary tumors. 2. Severe impairment or insufficiency of heart, lung, liver, or kidney function; 3. People with non-glioblastoma-related and difficult-to-control mental illness or disorder; 4. Who were also in other clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| disease-free survival (DFS);Objective response rate (Orr);progression-free survival (PFS);progression-free survival (PFS);total survival rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Functional State Score; | — |
Countries
China
Contacts
Public Contactzhang Ruiping
Beijing Huaxin Hospital
Outcome results
None listed